Henry Schein (0L3C) Share Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0L3C Analyst Ratings

Moderate Buy

5 Buy

2 Hold

2 Sell

Based on 9 analysts giving stock ratings to

Henry

Schein

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0L3C Stock 12 Month Forecast

Average Price Target

$74.50

▲(4.09% Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Henry Schein in the last 3 months. The average price target is $74.50 with a high forecast of $87.00 and a low forecast of $58.00. The average price target represents a 4.09% change from the last price of $71.57.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"57":"$57","88":"$88","64.75":"$64.8","72.5":"$72.5","80.25":"$80.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":87,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$87.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":74.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$74.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$58.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[57,64.75,72.5,80.25,88],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,66.71,68.27076923076922,69.83153846153846,71.39230769230768,72.95307692307692,74.51384615384615,76.07461538461538,77.63538461538461,79.19615384615385,80.75692307692307,82.31769230769231,83.87846153846154,85.43923076923076,{"y":87,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,66.71,67.30923076923077,67.90846153846154,68.50769230769231,69.10692307692307,69.70615384615384,70.30538461538461,70.90461538461538,71.50384615384615,72.10307692307693,72.70230769230768,73.30153846153846,73.90076923076923,{"y":74.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,66.71,66.03999999999999,65.36999999999999,64.69999999999999,64.03,63.36,62.69,62.019999999999996,61.349999999999994,60.68,60.01,59.34,58.67,{"y":58,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":72.19,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.69,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.01,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.18,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.372,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.275,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.18,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.34,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.76,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.01,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.85,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.158,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.71,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$87.00

Average Price Target$74.50

Lowest Price Target$58.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael Cherny

Leerink Partners

$71→$75

Hold

4.79%

Upside

Reiterated

11/04/25

Henry Schein price target raised to $75 from $71 at LeerinkHenry Schein price target raised to $75 from $71 at Leerink

Brandon Vazquez

William Blair

―

Hold

―

Reiterated

11/04/25

Analysts' Top Healthcare Picks: Sarepta Therapeutics (SRPT), Henry Schein (HSIC)

Allen Lutz

Bank of America Securities

$83

Buy

15.97%

Upside

Reiterated

10/24/25

Henry Schein (HSIC) Gets a Buy from Bank of America Securities

Michael Petusky

Barrington

$78

Buy

8.98%

Upside

Reiterated

10/22/25

Positive Outlook for Henry Schein: Buy Rating with $78 Price Target Based on Strategic Positioning and Financial Performance

Daniel Rich

CFRA

$59

Sell

-17.56%

Downside

Downgraded

10/14/25

CFRA downgrades Henry Schein (HSIC) to a Sell

Elizabeth Anderson CFA

Evercore ISI

$83

Buy

15.97%

Upside

Reiterated

10/08/25

Evercore ISI Reaffirms Their Buy Rating on Henry Schein (HSIC)

Owen Mediport

TR | OpenAI - 4o

$76→$74

Hold

3.40%

Upside

Reiterated

09/25/25

AI Generated ArticleAI Generated Article

Jason Bednar

Piper Sandler

$77

Buy

7.59%

Upside

Reiterated

09/23/25

Henry Schein (HSIC) Gets a Buy from Piper Sandler

John Stansel

J.P. Morgan

$80→$76

Buy

6.19%

Upside

Reiterated

08/07/25

J.P. Morgan Keeps Their Buy Rating on Henry Schein (HSIC)

Jonathan Block

Stifel Nicolaus

$75→$70

Hold

-2.19%

Downside

Reiterated

08/06/25

Stifel Nicolaus Keeps Their Hold Rating on Henry Schein (HSIC)

Kevin Caliendo

UBS

$75→$70

Hold

-2.19%

Downside

Reiterated

08/06/25

Henry Schein price target lowered to $70 from $75 at UBSHenry Schein price target lowered to $70 from $75 at UBS

Steven Valiquette

Mizuho Securities

$76→$74

Hold

3.40%

Upside

Reiterated

08/06/25

Mizuho Securities Sticks to Its Hold Rating for Henry Schein (HSIC)

Vik Chopra

Wells Fargo

$75→$70

Hold

-2.19%

Downside

Reiterated

08/06/25

Henry Schein (HSIC) Receives a Hold from Wells Fargo

Jeff Johnson

Robert W. Baird

$72

Hold

0.60%

Upside

Downgraded

07/11/25

Hold Rating on Henry Schein Amid Uncertainty Over Heartland Dental's Potential Shift

Erin Wright

Morgan Stanley

$55

Sell

-23.15%

Downside

Reiterated

04/15/25

Morgan Stanley Keeps Their Sell Rating on Henry Schein (HSIC)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael Cherny

Leerink Partners

$71→$75

Hold

4.79%

Upside

Reiterated

11/04/25

Henry Schein price target raised to $75 from $71 at LeerinkHenry Schein price target raised to $75 from $71 at Leerink

Brandon Vazquez

William Blair

―

Hold

―

Reiterated

11/04/25

Analysts' Top Healthcare Picks: Sarepta Therapeutics (SRPT), Henry Schein (HSIC)

Allen Lutz

Bank of America Securities

$83

Buy

15.97%

Upside

Reiterated

10/24/25

Henry Schein (HSIC) Gets a Buy from Bank of America Securities

Michael Petusky

Barrington

$78

Buy

8.98%

Upside

Reiterated

10/22/25

Positive Outlook for Henry Schein: Buy Rating with $78 Price Target Based on Strategic Positioning and Financial Performance

Daniel Rich

CFRA

$59

Sell

-17.56%

Downside

Downgraded

10/14/25

CFRA downgrades Henry Schein (HSIC) to a Sell

Elizabeth Anderson CFA

Evercore ISI

$83

Buy

15.97%

Upside

Reiterated

10/08/25

Evercore ISI Reaffirms Their Buy Rating on Henry Schein (HSIC)

Owen Mediport

TR | OpenAI - 4o

$76→$74

Hold

3.40%

Upside

Reiterated

09/25/25

AI Generated ArticleAI Generated Article

Jason Bednar

Piper Sandler

$77

Buy

7.59%

Upside

Reiterated

09/23/25

Henry Schein (HSIC) Gets a Buy from Piper Sandler

John Stansel

J.P. Morgan

$80→$76

Buy

6.19%

Upside

Reiterated

08/07/25

J.P. Morgan Keeps Their Buy Rating on Henry Schein (HSIC)

Jonathan Block

Stifel Nicolaus

$75→$70

Hold

-2.19%

Downside

Reiterated

08/06/25

Stifel Nicolaus Keeps Their Hold Rating on Henry Schein (HSIC)

Kevin Caliendo

UBS

$75→$70

Hold

-2.19%

Downside

Reiterated

08/06/25

Henry Schein price target lowered to $70 from $75 at UBSHenry Schein price target lowered to $70 from $75 at UBS

Steven Valiquette

Mizuho Securities

$76→$74

Hold

3.40%

Upside

Reiterated

08/06/25

Mizuho Securities Sticks to Its Hold Rating for Henry Schein (HSIC)

Vik Chopra

Wells Fargo

$75→$70

Hold

-2.19%

Downside

Reiterated

08/06/25

Henry Schein (HSIC) Receives a Hold from Wells Fargo

Jeff Johnson

Robert W. Baird

$72

Hold

0.60%

Upside

Downgraded

07/11/25

Hold Rating on Henry Schein Amid Uncertainty Over Heartland Dental's Potential Shift

Erin Wright

Morgan Stanley

$55

Sell

-23.15%

Downside

Reiterated

04/15/25

Morgan Stanley Keeps Their Sell Rating on Henry Schein (HSIC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Henry Schein

1 Month

xxx

Success Rate

11/22 ratings generated profit

Average Return

-0.74%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -0.74% per trade.

3 Months

xxx

Success Rate

19/36 ratings generated profit

Average Return

+1.20%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 52.78% of your transactions generating a profit, with an average return of +1.20% per trade.

1 Year

Jason BednarPiper Sandler

Success Rate

8/22 ratings generated profit

Average Return

-1.79%

reiterated a buy rating last month

Copying Jason Bednar's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -1.79% per trade.

2 Years

xxx

Success Rate

6/36 ratings generated profit

Average Return

-7.80%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -7.80% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0L3C Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0L3C has received 16 Buy Ratings, 17 Hold Ratings, and 1 Sell Ratings. 0L3C average Analyst price target in the past 3 months is 74.50.

Each month's total comprises the sum of three months' worth of ratings.

0L3C Financial Forecast

0L3C Earnings Forecast

Next quarter’s earnings estimate for 0L3C is $1.29 with a range of $1.24 to $1.38. The previous quarter’s EPS was $1.38. 0L3C beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 0L3C has Preformed in-line its overall industry.

0L3C Sales Forecast

Next quarter’s sales forecast for 0L3C is $3.34B with a range of $3.26B to $3.37B. The previous quarter’s sales results were $3.34B. 0L3C beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 0L3C has Preformed in-line its overall industry.

0L3C Stock Forecast FAQ

What is GB:0L3C’s average 12-month price target, according to analysts?

Based on analyst ratings, Henry Schein’s 12-month average price target is 74.50.

What is GB:0L3C’s upside potential, based on the analysts’ average price target?

Henry Schein has 4.09% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Henry Schein a Buy, Sell or Hold?

Henry Schein has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 2 hold ratings and 2 sell ratings.

What is Henry Schein’s share price target?

The average share price target for Henry Schein is 74.50. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $87.00 ,and the lowest forecast is $58.00. The average share price target represents 4.09% Increase from the current price of $71.57.

What do analysts say about Henry Schein?

Henry Schein’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of Henry Schein?

To buy shares of GB:0L3C, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Henry Schein (0L3C) Share Forecast & Price Target

0L3C Analyst Ratings

0L3C Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Henry Schein

0L3C Analyst Recommendation Trends

0L3C Financial Forecast

0L3C Earnings Forecast

0L3C Sales Forecast

0L3C Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts